Folger Nolan Fleming Douglas Capital Management Inc. lessened its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 18,116 shares of the company’s stock after selling 135 shares during the quarter. Folger […]
First Fiduciary Investment Counsel Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,314 shares of the company’s stock after purchasing an additional 131 shares during the period. First Fiduciary Investment Counsel Inc.’s […]
AbbVie (NYSE:ABBV – Get Free Report) issued an update on its FY24 earnings guidance on Friday morning. The company provided earnings per share guidance of $11.13-$11.33 for the period, compared to the consensus earnings per share estimate of $11.12. AbbVie also updated its Q2 2024 guidance to 3.050-3.090 EPS. AbbVie Stock Down 4.6 % NYSE:ABBV […]
Private Wealth Partners LLC decreased its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.6% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 154,947 shares of the company’s stock after selling 2,440 shares during the quarter. AbbVie makes up approximately […]
Valmark Advisers Inc. reduced its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,316 shares of the company’s stock after selling 526 shares during the quarter. Valmark Advisers Inc.’s holdings […]